News: stephen fesik

Fesik’s Cancer Research Achievements Honored

Friday, March 30th, 2012

Stephen Fesik, Ph.D., professor of Biochemistry, Pharmacology and Chemistry at Vanderbilt, will receive the 2012 AACR Award for Outstanding Achievement in Chemistry in Cancer Research. Fesik, who holds the Orrin H. Ingram II chair in cancer research, will receive the special recognition during the American Association for Cancer Research (AACR) Annual Meeting in Chicago March […]

My Health Chat: Cancer Drug Discovery

Thursday, March 22nd, 2012

The April program for My Health Chat will be the promising world of cancer drug discovery. Panelists will be Lawrence Marnett, Ph.D., director of the Vanderbilt Institute of Chemical Biology, and Stephen Fesik, Ph.D., director of drug discovery at Vanderbilt-Ingram Cancer Center. They will be discussing and taking questions about how information about the genetic […]

Carroll Wins Vanderbilt’s First Damon Runyon Fellowship

Friday, January 27th, 2012

Mary Carroll, Ph.D., a postdoctoral research fellow in Biochemistry, was recently named one of 18 Damon Runyon Fellows by the Damon Runyon Cancer Research Foundation. The three-year, $156,000 award provides independent funding for outstanding postdoctoral scientists to pursue innovative projects. Carroll is the first postdoctoral fellow from Vanderbilt to receive this award. “I am honored […]

Magnet to Enhance Cancer Drug Discovery

Friday, May 13th, 2011

Onlookers cheered early on the morning of Saturday, May 7, as a shattering champagne bottle christened the delivery of a $5 million, 7.5-ton magnet to Vanderbilt University. The magnet is the main part of an ultra-high field, 900 megahertz nuclear magnetic resonance (NMR) spectrometer that will help researchers solve the mysteries of cancer, Alzheimer’s disease […]

Grant Bolsters Pancreatic Cancer Research

Monday, January 31st, 2011

Stephen Fesik, Ph.D., professor of Biochemistry, Pharmacology and Chemistry, has received a $2.5 million grant to fund research on drugs for the treatment of pancreatic cancer. The three-year award from the Lustgarten Foundation will support Fesik’s work on targeting K-Ras, a protein that is mutated in 90 percent of pancreatic cancer patients. Approximately 43,140 patients […]

Seven VU Faculty Honored

Wednesday, January 12th, 2011

Nashville, Tenn. – Seven Vanderbilt University faculty members, including 6 who are members of the Vanderbilt-Ingram Cancer Center, have been elected Fellows of the American Association for the Advancement of Science (AAAS), an honor bestowed upon them by their AAAS peers. They are among 503 AAAS members from around the country who achieved this honor […]

Fesik Receives NIH Pioneer Award

Friday, August 13th, 2010

Stephen Fesik, Ph.D., has been awarded a National Institutes of Health Director’s Pioneer Award for his proposal to push the boundaries of drug discovery. Fesik, the Orrin H. Ingram II Chair in Cancer Research, is the first investigator from Vanderbilt to receive this coveted award. The 17 researchers honored this year join the 81 other […]

Your Genome, Future of Medicine

Monday, June 21st, 2010

A new documentary about the exciting era of personalized medicine and health care is now available on YouTube. Your Genome and the Future of Medicine, developed by Vanderbilt University Medical Center, initially aired on local stations in Lexington, Ky., and Nashville, Tenn. The 30-minute documentary, available for viewing in four segments, features interviews with several […]